Helvetia Holding AG
LSE:0ACB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Helvetia Holding AG
LSE:0ACB
|
CH |
|
TherapeuticsMD Inc
NASDAQ:TXMD
|
US |
|
D
|
DPC Holdings Ltd
NYSE:DPC
|
UK |
|
K
|
Kvasir Education Ltd
TASE:KVSR
|
IL |
|
S
|
Shotspotter Inc
F:918
|
US |
|
I
|
in Veritas Medical Diagnostics Inc
OTC:IVME
|
UK |
|
G
|
Global Hydrogen SA
WSE:GHY
|
PL |
|
A
|
Arendals Fossekompani ASA
LSE:0DHA
|
NO |
Wall St Price Targets
0ACB Price Targets Summary
Helvetia Holding AG
According to Wall Street analysts, the average 1-year price target for 0ACB is 232.1983 CHF with a low forecast of 191.8962 CHF and a high forecast of 280.3443 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0ACB's stock price target?
Price Target
232.1983
CHF
According to Wall Street analysts, the average 1-year price target for 0ACB is 232.1983 CHF with a low forecast of 191.8962 CHF and a high forecast of 280.3443 CHF.
What is the Revenue forecast for Helvetia Holding AG?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 4 years is 6%.
What is the Net Income forecast for Helvetia Holding AG?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 3 years is 12%.
